---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-004148"
form_type: "8-K"
ticker: "TMCI"
cik: "0001630627"
company_name: "TREACE MEDICAL CONCEPTS, INC."
filed_at: "2023-02-23T23:59:59+00:00"
generated_at: "2026-06-19T02:44:20.479093+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Two co-founders to retire from Treace Medical board; director reclassified

## Summary
- F. Barry Bays and Thomas Timbie will retire from the Board at the 2023 annual meeting and not stand for re-election.
- Both have served since the company's founding in June 2014; retirements not due to any disagreement.
- Director Jane E. Kiernan reclassified as Class II director effective immediately before the 2023 annual meeting.
- Kiernan will stand for election as a Class II director at the 2023 annual meeting.

## SEC filing metadata
- accession: 0000950170-23-004148
- form_type: 8-K
- ticker: TMCI
- cik: 0001630627
- company_name: TREACE MEDICAL CONCEPTS, INC.
- filed_at: 2023-02-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1630627/000095017023004148/0000950170-23-004148-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1630627/000095017023004148/tmci-20230216.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-004148
- JSON: https://secwatch.observer/filing/0000950170-23-004148.json
- Plain text: https://secwatch.observer/filing/0000950170-23-004148.txt

## Key facts
- Executive change
  Thomas Timbie departed as Director at TREACE MEDICAL CONCEPTS, INC..
  - Action: retire
  - Role: Director
  source text: On February 16, 2023, F. Barry Bays and Thomas Timbie provided notice to the board of directors (the “ Board ”) of Treace Medical Concepts, Inc. (the “ Company ”) of their intent to retire from the Board at the expiration of their current terms at the 2023 annual meeting of stockholders (the “ 2023 Annual Meeting ”) and not to stand for re-election.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630627/000095017023004148/0000950170-23-004148-index.htm
- Executive change
  F. Barry Bays departed as Director at TREACE MEDICAL CONCEPTS, INC..
  - Action: retire
  - Role: Director
  source text: On February 16, 2023, F. Barry Bays and Thomas Timbie provided notice to the board of directors (the “ Board ”) of Treace Medical Concepts, Inc. (the “ Company ”) of their intent to retire from the Board at the expiration of their current terms at the 2023 annual meeting of stockholders (the “ 2023 Annual Meeting ”) and not to stand for re-election.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630627/000095017023004148/0000950170-23-004148-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.